Celsion Corporation (CLSN) |
|
1.82 0.05 (2.82%)
|
07-15 16:00 |
|
Open: |
1.77 |
Pre. Close: |
1.77 |
|
High:
|
1.8321 |
Low:
|
1.77 |
|
Volume:
|
117,136 |
Market Cap:
|
37M |
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.832 - 1.839 |
1.839 - 1.845 |
|
Low:
|
1.752 - 1.76 |
1.76 - 1.767 |
|
Close:
|
1.807 - 1.82 |
1.82 - 1.831 |
|
Technical analysis |
as of: 2019-07-15 4:41:03 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 2.19  One year: 2.31 |
| Support: |
Support1: 1.70 Support2: 1.41 |
| Resistance: |
Resistance1: 1.87 Resistance2: 1.98 |
| Pivot: |
1.77 |
| Moving Average: |
MA(5): 1.78 MA(20): 1.78
MA(100): 2.08  MA(250): 2.23 |
| MACD: |
MACD(12,26): -0.04 Signal(9): -0.06 |
| Stochastic oscillator: |
%K(14,3): 33.67 %D(3): 28.62 |
| RSI: |
RSI(14): 49.81 |
| 52-week: |
High: 3.10 Low: 1.35 Change(%): -38.9 |
| Average Vol(K): |
3-Month: 11162 10-Days: 7392 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.CLSN has closed below upper band by 10.2%. Bollinger Bands are 62.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to CLSN's normal range. The bands have been in this narrow range for 11 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Tue, 14 May 2019 20:17:07 Z
Pre-Market Earnings Report for May 15, 2019 : BABA, M, TSG, PLCE, TSEM, ERJ, PPDF, VERU, PERI, VBLT, POLA, CLSN
Mon, 13 May 2019 15:17:08 Z
Blueprint Medicines (BPMC) Q1 Earnings & Sales Lag Estimates
Mon, 13 May 2019 15:12:59 Z
Is Celsion (CLSN) Stock Outpacing Its Medical Peers This Year?
Fri, 10 May 2019 16:03:34 Z
Puma Biotech (PBYI) Q1 Earnings Top, Nerlynx Disappoints
Fri, 10 May 2019 16:02:40 Z
Spectrum Pharma (SPPI) Q1 Earnings Lag Estimates, Revenues Nil
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
20.48 |
| Shares Float (M) |
20.15 |
|
% Held by Insiders
|
1.65 |
|
% Held by Institutions
|
9.96 |
|
Shares Short (K)
|
513 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-0.545 |
|
EPS Est. Current Year
|
-3.500 |
|
EPS Est. Next Year
|
-1.170 |
|
EPS Est. Next Quarter
|
-0.390 |
|
Forward EPS
|
-3.105 |
|
Book Value (p.s.)
|
1.090 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
-4328.89 |
|
Return on Assets (ttm)
|
-30.3 |
|
Return on Equity (ttm)
|
-43.4 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
-0.555 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-1.035 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-7.92 |
|
Levered Free Cash Flow (M)
|
-9.58 |
Stock Valuations |
|
P/E
|
-3.34 |
|
P/E Growth Ratio
|
0.03 |
|
P/BV
|
1.67 |
|
P/S
|
1242453376.00 |
|
P/CF
|
-4.71 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
2017-05-30 |
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
